May 15, 2022
Boehringer Ingelheim’s Latest Investigational Treatment Slowed Lung Function Decline in People Living with Idiopathic Pulmonary Fibrosis
April 21, 2022
Boehringer Ingelheim Launches RenuTend™: a New Stem Cell Therapy to Improve the Healing of Tendon and Suspensory Ligament Injuries in Horses
April 20, 2022
VantAI Forms Research Collaboration with Boehringer Ingelheim to Identify Novel Protein Degraders
No current content.